Jonathan Hughes
Stock Analyst at Raymond James
Total Price Targets
8
Stocks Covered
7
Sectors
Financial Services, Real Estate
Most Recent
Sep 15, 2025
Notable Calls (Last 12 Months)
Stocks Covered by Jonathan Hughes
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| DOC | Healthpeak Properties, Inc. | $20.00 | $16.46 | +21.5% | 1 | Sep 15, 2025 |
| CTRE | CareTrust REIT, Inc. | $39.00 | $39.28 | -0.7% | 1 | Sep 2, 2025 |
| EGP | EastGroup Properties, Inc. | $190.00 | $200.56 | -5.3% | 1 | Apr 14, 2025 |
| CUBE | CubeSmart | $50.00 | $40.24 | +24.3% | 2 | Jul 23, 2024 |
| ADC | Agree Realty Corporation | $48.00 | $76.73 | -37.4% | 1 | Jun 3, 2024 |
| PSA | Public Storage | $330.00 | $301.37 | +9.5% | 1 | Mar 28, 2024 |
| MPT | Medical Properties Trust, Inc. | $26.00 | $5.08 | +412.3% | 1 | Oct 29, 2021 |
Recent Activity
- Sep 15, 2025— Set$20.00price target onDOC(Healthpeak Properties, Inc.)
- Sep 2, 2025— Set$39.00price target onCTRE(CareTrust REIT, Inc.)
- Apr 14, 2025— Set$190.00price target onEGP(EastGroup Properties, Inc.)
- Jul 23, 2024— Set$50.00price target onCUBE(CubeSmart)
- Jun 3, 2024— Set$48.00price target onADC(Agree Realty Corporation)
- Mar 28, 2024— Set$330.00price target onPSA(Public Storage)
- May 23, 2022— Set$52.00price target onCUBE(CubeSmart)
- Oct 29, 2021— Set$26.00price target onMPT(Medical Properties Trust, Inc.)
Frequently Asked Questions
Who is Jonathan Hughes?
Jonathan Hughes is a stock analyst at Raymond James covering 7 stocks primarily in Financial Services, Real Estate. They have issued 8 price targets since Oct 29, 2021.
What stocks does Jonathan Hughes cover?
Jonathan Hughes currently covers 7 stocks, including CUBE, DOC, CTRE, EGP, ADC.
What is Jonathan Hughes's latest price target?
Jonathan Hughes's most recent price target was $20.00 on DOC (Healthpeak Properties, Inc.), set on Sep 15, 2025.
What is Jonathan Hughes's highest price target?
Jonathan Hughes's highest issued price target is $330.00 on PSA, set on Mar 28, 2024.
More Analysts at Raymond James
Coverage based on publicly published price targets. Not investment advice.